Researchers Develop Conductive Microsheet Electrode for Skin Biosignal Recording
A team from the University of Tokyo and partner institutions created a fully conductive microsheet electrode using polyurethane and self-doped PEDOT. The electrode records electrocardiograms in high-temperature, high-sweat environments such as saunas.
link.springer.comResearchers at the University of Tokyo and collaborating institutions developed a microsheet electrode designed for on-skin biosignal measurement. The electrode combines polyurethane with self-doped poly(3,4-ethylenedioxythiophene) to achieve conductivity on both sides of the sheet.
The device shows a sheet resistance of 2–4 kΩ per square and an adhesion energy of 60 µJ per square centimeter. It maintains air stability for up to three weeks, according to the study published in npj Flexible Electronics.
The electrode recorded electrocardiograms inside a sauna where temperatures exceeded 90 °C and heavy sweating occurred. The fully conductive construction eliminates the need to insert wires between the skin and the electrode. The work addresses limitations of earlier nano-sheet electrodes that typically offered conductivity on only one side of an insulating film.
The new design aims to improve flexibility, gas permeability, and stable attachment during human motion. The study received support from AMED under grant number JP243fa627001. It was published online on 24 May 2026.
Key Facts
Story Timeline
3 events- 01 April 2025
Manuscript received by npj Flexible Electronics.
1 sourcenature.com - 11 May 2026
Manuscript accepted for publication.
1 sourcenature.com - 24 May 2026
Article published online describing the microsheet electrode.
1 sourcenature.com
Potential Impact
- 01
The electrode may enable longer-term biosignal monitoring during physical activity.
- 02
Further development could support integration into wearable medical devices.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…